When Congress passed the Dietary Supplement Health and Education Act in 1994, dietary supplements were placed in a unique marketing position. Unlike prescription drugs, which must be rigorously tested to prove both safety and efficacy before they are approved by the Food and Drug Administration (FDA) for commercial release, dietary supplements can go to market immediately. The FDA monitors the “claim” to ensure there is no implied cure wording and the Federal Trade Commission (FTC) assesses the truthfulness of the label claim only if there is a complaint.
The FDA's New Dietary Ingredient (NDI) draft guidance, released this past August, continues to shake up the supplement industry. Companies are struggling to understand what the new guidelines mean and exactly how the changes will impact their product lines once implemented.
There is more than one successful pathway to market. Understanding the regulatory nuances of each, and developing a solid product plan in advance, is essential for staying on time, on budget and keeping consistent with your brand strategy.
As the dust settles from another outstanding SupplySide West show, we take a moment to recap key highlights from the event.
Trend-spotting on the show floor
The convention hall was buzzing with activity as vendors, suppliers and retailers talked shop and did business. As expected, the latest and greatest products were on full display. Here are a few key themes we spotted:
As the probiotic segment continues to trend upward, more companies are investing in well-designed clinical trials to support efficacy.
One area that has presented substantial learning opportunities, and has helped shape the future of probiotic clinical trials, is the study of antibiotic associated diarrhea (AAD) and probiotic intake.
As the global voice of probiotics, the International Probiotics Association (IPA) has been working jointly with industry, government and academia to advance probiotic technology, research and product development.
Choosing a contract research organization (CRO) is one of the most important steps in a dietary supplement research and development plan.
With summer coming to a close, it's time to shift our mindsets away from backyard barbecues and toward our packed fall calendars.
Last month, industry experts in the joint and bone health sector gathered for an online event focused on the state of the market, the need for innovation and the future of joint and bone health products.
In the second part of our Ingredient Claims Confusion webinar recap (see Part 1 here), we highlight top tips for creating safe and effective new products from Greg Horn, President of Speciality Nutrition Group Inc.